DOI: 10.1128/AAC.02306-17
Article Information
PubMed
Published By
History
- Received November 15, 2017
- Returned for modification December 18, 2017
- Accepted February 17, 2018
- Published online April 26, 2018.
Copyright & Usage
Copyright © 2018 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (March 05, 2018).
- You are viewing the most recent version of this article.
Author Information
- Maria Goul Andersena,
- Anders Thorstedb,
- Merete Storgaarda,
- Anders N. Kristofferssonb,
- Lena E. Fribergb and
- Kristina Öbrink-Hansena
- aDepartment of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
- bDepartment of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden
- Address correspondence to Maria Goul Andersen, mariagoulandersen{at}gmail.com.
Citation Andersen MG, Thorsted A, Storgaard M, Kristoffersson AN, Friberg LE, Öbrink-Hansen K. 2018. Population pharmacokinetics of piperacillin in sepsis patients: should alternative dosing strategies be considered? Antimicrob Agents Chemother 62:e02306-17. https://doi.org/10.1128/AAC.02306-17.
